Avadel Pharmaceuticals (AVDL) Receivables Refunds (2016 - 2022)
Historic Receivables Refunds for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Q3 2022 value amounting to $2.1 million.
- Avadel Pharmaceuticals' Receivables Refunds fell 1668.67% to $2.1 million in Q3 2022 from the same period last year, while for Sep 2022 it was $2.1 million, marking a year-over-year decrease of 1668.67%. This contributed to the annual value of $2.4 million for FY2021, which is 2654.84% down from last year.
- Latest data reveals that Avadel Pharmaceuticals reported Receivables Refunds of $2.1 million as of Q3 2022, which was down 1668.67% from $2.2 million recorded in Q2 2022.
- Avadel Pharmaceuticals' Receivables Refunds' 5-year high stood at $3.3 million during Q4 2020, with a 5-year trough of $283000.0 in Q4 2018.
- For the 5-year period, Avadel Pharmaceuticals' Receivables Refunds averaged around $2.3 million, with its median value being $2.4 million (2021).
- Per our database at Business Quant, Avadel Pharmaceuticals' Receivables Refunds surged by 64452.3% in 2019 and then crashed by 2654.84% in 2021.
- Avadel Pharmaceuticals' Receivables Refunds (Quarter) stood at $283000.0 in 2018, then soared by 644.52% to $2.1 million in 2019, then soared by 57.85% to $3.3 million in 2020, then decreased by 26.55% to $2.4 million in 2021, then fell by 14.98% to $2.1 million in 2022.
- Its Receivables Refunds stands at $2.1 million for Q3 2022, versus $2.2 million for Q2 2022 and $2.4 million for Q1 2022.